Experienced scientist to boost Sakata's biotechnology research

As Senior Biotechnology Manager, Lindbo will be responsible for the management of the biotechnology team, which includes marker-assisted selection, marker discovery, and a new tissue culture lab for developing di-haploid lines in multiple crops.

"John will play an integral part in the Global Biotech Working Group at Sakata through collaboration with headquarters in Japan and affiliates in France and Brazil. His extensive knowledge and skillset in the biotechnology field will be vitally important to our efforts to increase capabilities in biotechnology and help Sakata to map the future capability of this function," says Jeff Zischke, Senior Director of Research and Development at Sakata Seed.

Lindbo has a Ph.D. in Microbiology from Oregon State University. For his graduate thesis work, he genetically engineered plants to be immune to tobacco etch potyvirus infection, defining the RNA interference approach to resistance. After completing his doctorate, he did a post-doc at University of California Davis in the Center for Engineering Plants for Resistance Against Pathogens (CEPRAP).

In addition to his pioneering work in RNA interference, Lindbo boasts an extensive career in plants and biotechnology. Throughout his diverse professional history, he taught undergraduate biology courses at Pacific Lutheran University in Tacoma, WA, worked as a Senior Scientist for a biotech startup company, taught and researched virology as an Assistant Professor at Ohio State University Department of Plant Pathology, and worked as a research scientist at UC Davis Department of Plant Pathology. In 2009, he began work in the seed industry at Campbell's Seeds managing the molecular marker program and labs. Following Campbell's acquisition by HM Clause in 2012, he continued work at HM Clause, where he developed new tools, techniques, and traits for use in plant breeding.

Click here to read more.

Photo created by DCStudio - www.freepik.com

Source: Greenhouse Grower